BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon

NCT02247310 · clinicaltrials.gov ↗

COMPLETED

Status

498

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing Remitting

Interventions

DRUG: Interferon beta-1b (Betaferon®, BAY 86-5046)
DEVICE: BETACONNECT

Sponsor

Bayer